| (2) |
The center:
| (a) |
shall seek state, federal, and private funds to award grants for medical cannabis research; |
| (b) |
shall facilitate and support funding for research related to the health effects, including the potential risks or side effects, of the use of cannabis products; |
| (c) |
shall facilitate and support funding for research related to the efficacy and potential health effects of various cannabis delivery methods, including vaporizing, ingesting, topical application, and combustion; |
| (d) |
shall support researchers in applying for and securing federal and private research grant funding for expanding medical cannabis research; |
| (e) |
shall review current and future cannabis research literature, clinical studies, and clinical trials; |
| (f) |
shall educate medical providers, lawmakers, and the public about medical cannabis research advances; |
| (g) |
shall, if requested, consult with researchers and eligible institutions seeking to conduct medical cannabis research regarding legal implications of the research under state and federal law; |
| (h) |
shall monitor, to the extent that appropriate and sufficient data are available, patient outcomes in any state with a medicinal cannabis program; |
| (i) |
may coordinate, share knowledge, and share best practices with a state:
| (i) |
that has a medical cannabis program; and |
| (ii) |
is conducting cannabis research; |
|
| (j) |
may award or facilitate funding for grants to an eligible institution for medical cannabis research, including research regarding the growing of a medical-grade cannabis plant that is used for a cannabis product; |
| (k) |
shall support a licensed cannabis cultivation facility to provide medical-grade cannabis products for research; |
| (l) |
shall make, for research conducted by the center, the research outcomes publicly available; |
| (m) |
shall maintain a catalog of all published scientific reports based on projects funded or managed by the center; |
| (n) |
shall ensure that an individual who agrees to use a cannabis product as part of a research project conducted by the center or a grantee has:
| (i) |
a valid medical cannabis patient card from the state; or |
| (ii) |
if included in the research project as a resident of another state, the equivalent of a medical cannabis patient card under the laws of another state, district, territory, commonwealth, or insular possession of the United States; |
|
| (o) |
shall obtain an academic research cannabis license; |
| (p) |
may apply for, or assist an eligible institution to apply for, a federal cannabis cultivation registration to locate a cannabis cultivation site in Utah; and |
| (q) |
for the report described in Section 26-61a-703, shall provide information to the Department of Health and Human Services describing:
| (i) |
all research projects that are funded by a grant awarded by the center, including which institution received the grant; |
| (ii) |
all research projects conducted by the center; and |
| (iii) |
the adequacy of funding for the center’s duties. |
|
|
